| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Davion Healthcare PLC
13D/A
G2779R101
|
41.1% |
8/11/2026
Event 8/11/2026
|
||||
| Jack Harry Kaye | 41.1% | |||||
| Rallinson Corp | 0% | |||||
| Rallinson Ltd | 0% | |||||
|
Davion Healthcare PLC
13D
G27599102
|
20.6% |
4/17/2026
Event 11/28/2025
|
||||
| Jack Harry Kaye | 20.6% | |||||
| Rallinson Corp | 4.99% | |||||
| Rallinson Ltd | 15.4% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.